Accuray Set to Reveal Q1 Fiscal 2026 Financial Results Soon

Author: Evelyn Baker Updated: 10-28-2025 07:39 AM

Accuray to Announce Financial Results for First Quarter

Accuray Incorporated (NASDAQ: ARAY) is gearing up to release its financial outcomes for the first quarter of fiscal year 2026, which concluded on September 30, 2025. The announcement is scheduled for November 5, 2025, with a conference call following at 1:30 p.m. Pacific Time.

Join the Conference Call

Investors and stakeholders are encouraged to participate in this informative call. The dial-in numbers for the call are 1-833-316-0563 for USA participants or 1-412-317-5747 for those calling internationally. A replay of the concall will be made available approximately one hour after it concludes, with access for one week. The replay can be reached by calling 1-855-669-9658 for USA participants or 1-412-317-0088 for international participants, using conference ID 7403898.

How to Access the Live Webcast

A live webcast will also be accessible from the Investor Relations section of Accuray's website. Listeners can visit the company's investor page to access the live stream and replay of the discussion, ensuring they stay informed about the latest financial developments.

Commitment to Radiation Therapy Innovations

Accuray is at the forefront of enhancing the power of radiation therapy designed to improve countless lives. The company is dedicated to creating groundbreaking, market-leading solutions that facilitate radiation treatments for both complex and straightforward cases alike. This dedication informs their mission to better meet various patient needs.

Continuous Innovations in Healthcare

The firm emphasizes ongoing advancements in radiation therapy for various applications, including oncology and neuro-radiosurgery. By collaborating with healthcare professionals and administrators, Accuray is empowering them to help patients achieve quicker recovery times and return to their daily lives.

About Accuray

Headquartered in Madison, Wisconsin, Accuray operates with a global presence. The company is staunchly focused on advancing treatment methodologies through technological innovations. Their efforts have led to the development of unique treatment capabilities in the field of radiation therapy.

Get Involved with Accuray

For those interested in learning more about Accuray's innovative solutions and commitment to patient care, their official website provides a wealth of information.

Investor and Public Relations Contacts

For investor inquiries, Aman Patel, CFA, is the key contact in Investor Relations at ICR Healthcare. Interested parties can reach out to him for further discussions on investment opportunities or financial performances.

Additionally, Beth Kaplan serves as the Public Relations Director for the company, managing media relations and public inquiries.

Frequently Asked Questions

What date will Accuray report its financial results?

Accuray will report its financial results for the first quarter on November 5, 2025.

How can I listen to the earnings call?

You can listen to the near live earnings call by dialing in at 1-833-316-0563 for the USA or 1-412-317-5747 for international callers.

Is there a way to access a replay of the call?

Yes, a replay will be available about an hour after the call concludes, accessible for one week thereafter.

What is Accuray's primary focus?

Accuray is focused on providing innovative solutions in radiation therapy to meet diverse patient needs.

Where is Accuray located?

Accuray is headquartered in Madison, Wisconsin, with facilities around the world.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.